The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme.
about
High levels of c-Met is associated with poor prognosis in glioblastoma.Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse modelsNovel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approach.MET immunolabelling is a useful predictive tool for MET gene amplification in glioblastoma.
P2860
The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The immunohistochemical expres ...... with glioblastoma multiforme.
@en
The immunohistochemical expres ...... with glioblastoma multiforme.
@nl
type
label
The immunohistochemical expres ...... with glioblastoma multiforme.
@en
The immunohistochemical expres ...... with glioblastoma multiforme.
@nl
prefLabel
The immunohistochemical expres ...... with glioblastoma multiforme.
@en
The immunohistochemical expres ...... with glioblastoma multiforme.
@nl
P2093
P2860
P1476
The immunohistochemical expres ...... with glioblastoma multiforme.
@en
P2093
A Deligonul
O Manavoglu
P2860
P2888
P304
P356
10.1007/S12094-013-1059-4
P577
2013-06-06T00:00:00Z